Platelet-Rich Fibrin Decreases the Inflammatory Response of Mesenchymal Cells
- PMID: 34768764
- PMCID: PMC8583104
- DOI: 10.3390/ijms222111333
Platelet-Rich Fibrin Decreases the Inflammatory Response of Mesenchymal Cells
Abstract
Chronic inflammation is a pathological process where cells of the mesenchymal lineage become a major source of inflammatory mediators. Platelet-rich fibrin (PRF) has been shown to possess potent anti-inflammatory activity in macrophages, but its impact on mesenchymal cells has not been investigated. The aim of this study was, therefore, to expose mesenchymal cells to inflammatory cytokines together with lysates generated from liquid platelet-poor plasma (PPP), the cell-rich buffy coat layer (BC; concentrated-PRF or C-PRF), and the remaining red clot layer (RC), following centrifugation of blood. Heating PPP generates an albumin gel (Alb-gel) that when mixed back with C-PRF produces Alb-PRF. Membranes prepared from solid PRF were also subjected to lysis. We report here that lysates of PPP, BC, and PRF decreased the cytokine-induced expression of interleukin 6 (IL6) and nitric oxide synthase (iNOS) in the bone marrow-derived ST2 cells. Consistently, PPP, BC, and PRF greatly decreased the phosphorylation and nuclear translocation of p65 in ST2 cells. The inflammatory response caused by Pam3CSK4 was reduced accordingly. Moreover, PPP, BC, and PRF reduced the enhanced expression of inflammatory mediators IL6 and iNOS in 3T3-L1 pre-adipocyte mesenchymal cells, and iNOS and CCL5 in murine calvarial cells. Surprisingly, PRF lysates were not effective in reducing the inflammatory response of human gingival fibroblasts and HSC2 epithelial cells. The data from the present study suggest that both liquid PRF and solid PRF exert potent anti-inflammatory activity in murine mesenchymal cells.
Keywords: Toll-like receptor; cytokine; inflammation; mesenchymal cells; platelet-rich fibrin.
Conflict of interest statement
The authors declare no conflict of interest.
Figures








Similar articles
-
Liquid PRF Reduces the Inflammatory Response and Osteoclastogenesis in Murine Macrophages.Front Immunol. 2021 Apr 9;12:636427. doi: 10.3389/fimmu.2021.636427. eCollection 2021. Front Immunol. 2021. PMID: 33897689 Free PMC article.
-
Platelet-Rich Fibrin Increases BMP2 Expression in Oral Fibroblasts via Activation of TGF-β Signaling.Int J Mol Sci. 2021 Jul 25;22(15):7935. doi: 10.3390/ijms22157935. Int J Mol Sci. 2021. PMID: 34360701 Free PMC article.
-
Blood Clots versus PRF: Activating TGF-β Signaling and Inhibiting Inflammation In Vitro.Int J Mol Sci. 2022 May 24;23(11):5897. doi: 10.3390/ijms23115897. Int J Mol Sci. 2022. PMID: 35682575 Free PMC article.
-
Advances in separation methods for the use of platelet-rich fibrin in tissue repair: an integrative review.Gen Dent. 2023 Mar-Apr;71(2):65-69. Gen Dent. 2023. PMID: 36825976 Review.
-
Advantages of horizontal centrifugation of platelet-rich fibrin in regenerative medicine and dentistry.Periodontol 2000. 2025 Mar 25. doi: 10.1111/prd.12625. Online ahead of print. Periodontol 2000. 2025. PMID: 40130760 Review.
Cited by
-
Proof-of-Principle Study Suggesting Potential Anti-Inflammatory Activity of Butyrate and Propionate in Periodontal Cells.Int J Mol Sci. 2022 Sep 20;23(19):11006. doi: 10.3390/ijms231911006. Int J Mol Sci. 2022. PMID: 36232340 Free PMC article.
-
Promoting repair of highly purified stromal vascular fraction gel combined with advanced platelet-rich fibrin extract for irradiated skin and soft tissue injury.Ann Transl Med. 2022 Sep;10(17):933. doi: 10.21037/atm-22-3956. Ann Transl Med. 2022. PMID: 36172108 Free PMC article.
-
PRF Lysates Modulate Chemokine Expression in Oral Squamous Carcinoma and Healthy Epithelial Cells.Bioengineering (Basel). 2024 Jul 24;11(8):746. doi: 10.3390/bioengineering11080746. Bioengineering (Basel). 2024. PMID: 39199704 Free PMC article.
-
Molecular Research on Platelet Activity in Health and Disease 3.0.Int J Mol Sci. 2022 May 16;23(10):5530. doi: 10.3390/ijms23105530. Int J Mol Sci. 2022. PMID: 35628340 Free PMC article.
-
Ovarian recovery via autologous platelet-rich plasma: New benchmarks for condensed cytokine applications to reverse reproductive aging.Aging Med (Milton). 2022 Feb 5;5(1):63-67. doi: 10.1002/agm2.12196. eCollection 2022 Mar. Aging Med (Milton). 2022. PMID: 35309160 Free PMC article. Review.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous